These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36268004)

  • 1. Older age and depressive state are risk factors for re-positivity with SARS-CoV-2 Omicron variant.
    Li M; Peng H; Duan G; Wang J; Yu Z; Zhang Z; Wu L; Du M; Zhou S
    Front Public Health; 2022; 10():1014470. PubMed ID: 36268004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and mortality of SARS-CoV-2 reinfection during the Omicron era in Taiwan: A nationwide population-based cohort study.
    Chen YH; Lee CY; Cheng HY; Chen CM; Cheuh YN; Lee CL; Kuo HW
    J Microbiol Immunol Infect; 2024 Feb; 57(1):30-37. PubMed ID: 37978019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reinfection rate and disease severity of the BA.5 Omicron SARS-CoV-2 lineage compared to previously circulating variants of concern in the Canary Islands (Spain).
    Ciuffreda L; Lorenzo-Salazar JM; García-Martínez de Artola D; Gil-Campesino H; Alcoba-Florez J; Rodríguez-Pérez H; Íñigo-Campos A; Salas-Hernández J; Rodríguez-Nuñez J; Muñoz-Barrera A; Valenzuela-Fernández A; Díez-Gil O; González-Montelongo R; Flores C
    Emerg Microbes Infect; 2023 Dec; 12(1):2202281. PubMed ID: 37039029
    [No Abstract]   [Full Text] [Related]  

  • 4. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What contributes to the re-positive nucleic acid test results for the omicron variant of SARS-CoV-2 in the shelter cabin hospital in Shanghai, China?
    Peng M; Hu M; Peng X; Gong Y; Qian K; Li J; Zhao J; Li X; Huang J; Zhang M; Chai L; Chen L; Zhang D; Peng L
    Heliyon; 2023 May; 9(5):e15679. PubMed ID: 37124338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 reinfection with Omicron variant in Shaanxi Province, China: December 2022 to February 2023.
    Zhang M; Cao L; Zhang L; Li X; Chen S; Zhang Y
    BMC Public Health; 2024 Feb; 24(1):496. PubMed ID: 38365671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics and related factors of viral nucleic acid negative conversion in children infected with Omicron variant strain of SARS-CoV-2].
    Yin R; Lu Q; Jiao JL; Lin K; Wang C; Yuan L; Ding Y; Dong N; Wang BJ; Niu YH; Fang YS; Liu W; Sun YF; Zou B; Zhang XE; Xiao P; Sun L; Du X; Zhu YY; Dong XY
    Zhonghua Er Ke Za Zhi; 2022 Dec; 60(12):1307-1311. PubMed ID: 36444435
    [No Abstract]   [Full Text] [Related]  

  • 8. Distinguishing COVID-19 from seasonal influenza in patients under age 65 years-a retrospective observational cohort study comparing the 2009 influenza A (H1N1) and 2022 SARS-CoV-2 pandemics.
    Zhong W; Wu Y; Yue W; Fang J; Xie B; Xu N; Lin M; Zhu X; Su Z; Chen Y; Li H; Li H
    Front Cell Infect Microbiol; 2023; 13():1179552. PubMed ID: 37533930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
    Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
    PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental health symptoms and sleep quality of asymptomatic/mild SARS-CoV-2 infected individuals during the Omicron wave of the COVID-19 pandemic in Shanghai China.
    Hou Z; Huang Y; Ma S; Feng H; Fu C; Li H; Yuan Y; Yuan Y
    Brain Behav; 2022 Dec; 12(12):e2803. PubMed ID: 36326125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant Rise in SARS-CoV-2 Reinfection Rate in Vaccinated Hospital Workers during the Omicron Wave: A Prospective Cohort Study.
    Ochoa-Hein E; Leal-Morán PE; Nava-Guzmán KA; Vargas-Fernández AT; Vargas-Fernández JF; Díaz-Rodríguez F; Rayas-Bernal JA; González-González R; Vázquez-González P; Huertas-Jiménez MA; Rajme-López S; Ramos-Cervantes P; Ibarra-González V; García-Andrade LA; Ledesma-Barrientos F; Ponce-de-León A; Sifuentes-Osornio J; Galindo-Fraga A
    Rev Invest Clin; 2022; 74(4):175-180. PubMed ID: 36087938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease and social factors associated with healthcare utilization for the treatment of SARS-CoV-2 infections in a longitudinal cohort of essential workers in Arizona.
    Rivers P; Jovel K; Ramadan F; Barnett JJA; Ellingson KD; Burgess JL; Lutrick K
    BMC Health Serv Res; 2023 Oct; 23(1):1118. PubMed ID: 37853403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for SARS-CoV-2 re-positivity in COVID-19 patients after discharge.
    Hong LX; Liu L; Lin A; Yan WH
    Int Immunopharmacol; 2021 Jun; 95():107579. PubMed ID: 33756229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of viable virus shedding and polymerase chain reaction positivity of the SARS-CoV-2 Omicron variant in the upper respiratory tract: a systematic review and meta-analysis.
    Wu Y; Guo Z; Yuan J; Cao G; Wang Y; Gao P; Liu J; Liu M
    Int J Infect Dis; 2023 Apr; 129():228-235. PubMed ID: 36804640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [COVID-19 recurrence due to reinfection with SARS-CoV-2 in a hemodialysis patient: there and back again].
    Vigotti FN; Bianco S; Alfieri V; Bilucaglia D; Motta D; Pignataro A; Timbaldi M; Torta E; Cesano G
    G Ital Nefrol; 2022 Apr; 39(2):. PubMed ID: 35471003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity.
    Joung SY; Ebinger JE; Sun N; Liu Y; Wu M; Tang AB; Prostko JC; Frias EC; Stewart JL; Sobhani K; Cheng S
    JAMA Netw Open; 2022 Aug; 5(8):e2227241. PubMed ID: 35976645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors Related to COVID-19 Reinfection and Fatality During the Omicron (BA.1/BA.2) Period in Korea.
    Lee JH; Hwang JH; Jang EJ; Kim RK; Lee KH; Park SK; Gwack J; Park YJ
    J Korean Med Sci; 2023 Aug; 38(34):e269. PubMed ID: 37644683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-stage neutralizing antibody level associated with the re-positive risk of Omicron SARS-CoV-2 RNA in patients recovered from COVID-19.
    You T; Huang W; Huang X; Li E; Liu Y; Xue L; Chen X; Liu SR; Liu F; Bao JF
    Diagn Microbiol Infect Dis; 2024 May; 109(1):116158. PubMed ID: 38401184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-Covid-19 condition (Long Covid) in children and young people 12 months after infection or reinfection with the Omicron variant: a prospective observational study.
    Pinto Pereira SM; Nugawela MD; Stephenson T; Foret-Bruno P; Dalrymple E; Xu L; Whittaker E; Heyman I; Ford T; Segal T; Chalder T; Ladhani SN; Mensah AA; McOwat K; Simmons R; ; Shafran R
    Sci Rep; 2024 Apr; 14(1):9957. PubMed ID: 38693285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.